IDEAYA Biosciences (IDYA) Operating Leases (2019 - 2026)

IDEAYA Biosciences (IDYA) has 8 years of Operating Leases data on file, last reported at $28.2 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Leases rose 10.09% year-over-year to $28.2 million; the trailing twelve-month figure through Mar 2026 stood at $28.2 million (up 10.09% YoY), and the FY2025 full-year result was $27.6 million, up 46.11% from the prior year.
• Operating Leases grew to $28.2 million in Q1 2026, from $27.6 million in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $28.2 million in Q1 2026 to a low of $611000.0 in Q2 2023.
• A 5-year average of $11.7 million and a median of $2.8 million in 2022 frame the typical range for Operating Leases.
• Across the five-year window, Operating Leases slumped 76.24% in 2023 and soared 1980.68% in 2025, its largest moves.
• Tracing IDYA's Operating Leases over 5 years: stood at $1.6 million in 2022, then plunged by 30.17% to $1.1 million in 2023, then surged by 1577.6% to $18.9 million in 2024, then surged by 46.11% to $27.6 million in 2025, then rose by 2.45% to $28.2 million in 2026.
• Business Quant data shows IDYA's Operating Leases at $28.2 million in Q1 2026, $27.6 million in Q4 2025, and $26.9 million in Q3 2025.